Evidence map›Paper›PMID 33351109›Full record

ArticleBlood advances2020

IL-6 levels are dramatically high in the sputum from children with sickle cell disease during acute chest syndrome.

Slimane Allali, Mariane de Montalembert, Rachel Rignault-Bricard, Melissa Taylor, Joséphine Brice, Valentine Brousse, Jean-Marc Talbot, Florence Moulin, Claire Heilbronner, Olivier Hermine and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Slimane AllaliDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Mariane de MontalembertDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Rachel Rignault-BricardLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris, Imagine Institute, INSERM U1163, Paris, France.
Melissa TaylorDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Joséphine BriceDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Valentine BrousseDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Jean-Marc TalbotDepartment of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Florence MoulinPediatric Intensive Care Unit and.
Claire HeilbronnerPediatric Intensive Care Unit and.
Olivier HermineLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris, Imagine Institute, INSERM U1163, Paris, France.
Thiago Trovati MacielLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris, Imagine Institute, INSERM U1163, Paris, France.
Inserm · FRIntensive Care Society · GBUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Chest SyndromeAnemia, Sickle CellChildHumansInterleukin-6SputumIL6 protein, humanInterleukin-6

Identifiers

PMID33351109
PMCPMC7756999
OpenAlexW3112323674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.